Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

J Neuroimmune Pharmacol · 2013 · PMC3889247 · PMID 23649711

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

3a ), whereas the reduction of T cells producing IL-17 alone or in combination with IFN γ did not reach statistical significance (Fig. 3b and c ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.